Viewing a single comment thread. View all comments

technofuture8 t1_jdcview wrote

Reply to comment by Postnificent in How far are from repairing or even reviving dead nerves and muscles? by khaldood

Actually the main problem is, is that big pharma can't patent psilocybin. Psilocybin can't be patented and that's the problem.

2

Postnificent t1_jddedap wrote

It’s even deeper than that, it would really hurt the antidepressant market. They would rather do maintenance forever than cure a single person. Providing a cure to non deadly lifetime ailments isn’t the most profitable thing. How do you even value something like that? Whatever it is it’s going to cause backlash and they damn well know it. So the prudent course is to keep this life changing medication Federally on the same level as crack (I think the DEA has opened themselves to a lawsuit on this one as they have admitted it is medicine and non addictive yet it remains schedule 1 contrary to their own admission)

1

technofuture8 t1_jdejmas wrote

No my friend, if big pharma can't patent it then they have no interest in it.

1